Fluorescence-Based Functional Assay for Wnt/β-Catenin Signaling Activity

Aberrant activation of β-catenin signaling has been implicated in the development of human cancers. As a Wnt signal transducer, β-catenin forms a complex with the lymphocyte enhancer-binding factor/T cell factor transcription factor and activates downstream targets that promote cell proliferation. H...

Full description

Saved in:
Bibliographic Details
Published inBioTechniques Vol. 33; no. 5; pp. 1126 - 1135
Main Authors Zhou, L, An, N, Jiang, W, Haydon, R, Cheng, H, Zhou, Q, Breyer, B, Feng, T, He, T.-C
Format Journal Article
LanguageEnglish
Published England Future Science Ltd 01.11.2002
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aberrant activation of β-catenin signaling has been implicated in the development of human cancers. As a Wnt signal transducer, β-catenin forms a complex with the lymphocyte enhancer-binding factor/T cell factor transcription factor and activates downstream targets that promote cell proliferation. Here we developed a Wnt-dependent β-catenin-mediated heterologous transactivation system, which consisted of a chimeric transcription factor constructed by fusing the GAL4 DNA-binding domain with the full-length β-catenin, and a GAL4-responsive reporter expressing GFP. The chimeric transcription factor was highly unstable and exerted no detectable transactivating effect on the GAL4-responsive reporter. However, lithium and Wnt1 significantly stabilized this chimeric transactivator, indicating that this transactivation system is regulated by β-catenin in a Wnt-responsive fashion. Thus, this transactivation system could be used as a functional reporter to identify potential upstream factors that deregulate β-catenin signaling during tumorigenesis, as well as to screen for potential anti-cancer agents that specifically inhibit β-catenin signaling in human tumors.
ISSN:0736-6205
1940-9818
DOI:10.2144/02335dd07